Propanc Biopharma, Inc. , a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia.
Propanc Biopharma stock last closed at $0.11, up 4.46% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Propanc Biopharma stock is currently +3.92% from its 52-week low of $0.10, and -98.87% from its 52-week high of $9.36.
At the moment, there are 15.86M shares of PPCB outstanding. The market capitalization of PPCB is $1.68M. In the last 24 hours, 401,000 PPCB shares were traded.
You need an online brokerage account to access the NASDAQ market and buy PPCB shares.
In our opinion, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you need to fill out some personal details so you can invest in PPCB today.
Now that you've opened your account on one of the best stock apps, you can securely and quickly fund your account:
Check out the video below to see the process of transferring money into your new investment account.
Once you have figured out the best place to buy Propanc Biopharma stock, it's crucial to research their stock before you invest, so you actually wrap your head around the risk and opportunity.
WallStreetZen was designed to help average investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on PPCB's stock page.
You can use many financial metrics, analyses, models, and charts to gauge PPCB's fair value.
Using relative valuations metrics:
You can do additional valuation research on PPCB's stock here.
Last year, PPCB earnings were -$67.00M. During the past one years, PPCB's earnings have gone up by -99.06% per year. This was slower than the Biotechnology industry average of 20.19%.
Dive into PPCB's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at PPCB have not bought or sold any shares.
Learn more about who owns PPCB shares here.
No, Propanc Biopharma doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two main order types:
Press the Open button and eToro will place the order.
If you require additional help buying stocks on eToro, click the helpful video below:
Now that you own some PPCB shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track your PPCB stock.
To reiterate, here are the 6 steps to buy Propanc Biopharma stock:
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to track your investment in Propanc Biopharma, get started below.